Publication:
DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS

Simple item page
dc.contributor.authorsKoca, S. S.; Pehlivan, Y.; Akar, S.; Senel, S.; Karadeniz, H.; Sosyal, O.; Yazici, A.; Yilmaz, S.; Sagir, R. Piskin; Inanc, N.; Karatas, A.; Cetin, G. Yildirim; Onen, F.
dc.date.accessioned2022-03-12T04:22:59Z
dc.date.accessioned2026-01-11T16:23:38Z
dc.date.available2022-03-12T04:22:59Z
dc.date.issued2021-06
dc.identifier.doi10.1136/annrheumdis-2021-eular.2832
dc.identifier.eissn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/223858
dc.identifier.wosWOS:000692625300559
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleDISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage1317
oaire.citation.startPage1317
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume80

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
178.73 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları